Business
Technical Service
CADD: Addressing Unmet Needs in Drug Development Cost Efficiency
Accelerate your drug discovery projects with our innovative CADD solution integrating AI and molecular dynamics.
Collaborative R&D Milestone
Proposed Research Timeline
Contract
Signing
Signing
Hit Discovery
2–3 months
Hit-to-Lead
4–6 months
Lead Optimization
6–9 months
Contract
Completion
Completion
0
$150K
Upfront
1
$230K
Cumulative $380K
2
$230K
Cumulative $610K
3
$150K
Cumulative $760K
Hit Discovery
Discovery of Hit Scaffolds
IC/EC₅₀: sub-μM
or mutually agreed TPP criteria
1st Interim Report
System setup results, 1st screening results
- Literature-based target structure establishment
- Literature-based reference compound selection
-
In silico model construction
- Small-molecule/Peptide DB Adoption
- Commercial/Virtual Library Screening
- Molecular Docking
- Molecular Dynamics Simulation
- Binding Affinity Prediction
- Commercial DB primary screening
- Hit scaffold identification
Hit-to-Lead
Scaffold-based Ligand Optimization
IC/EC₅₀: ~1 μM
or mutually agreed TPP criteria
2nd Interim Report
Lead candidate chemical library/DB, 2nd screening results
- Scaffold structure-based lead generation
- In silico lead candidate chemical library construction
- Library-targeted 2nd lead virtual screening
- Hit candidate identification
Lead Optimization
In vitro Data-based Optimization
IC/EC₅₀: ~100 nM
or mutually agreed TPP criteria
Final Report
- Hit candidate in vitro data-based in silico model optimization
- ADME/T-focused lead optimization
- Final compound structure with optimized efficacy and structural novelty
Core Business
B2C/B2B Customized Platform Business Model
Project-based Platform SW Service
- Target-optimized SW license and technical support
- Conditions optimized for client's drug IP strategy
✓ Customer loyalty based on SW platform utility
Target-specific Drug Discovery Service
- Hit design for client's drug target (automatic SW acquisition with hit delivery)
✓ Atomatrix technology validation (PoC) effect